Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Winston Medical Supply CoROCO:6817 84 EV-to-EBIT is 4.97 as of Sep. 16, 2026, which is 51% below its 10-year median of 10.17. GuruFocus rates ROCO:6817 with a GF Score™ of 84/100 and a GF Value™ of NT$87.89 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 682 Drug Manufacturers companies, Winston Medical Supply Co ranks better than 89% on this metric.
Winston Medical Supply Co (ROCO:6817) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Winston Medical Supply Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$858.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Winston Medical Supply Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was NT$104.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Winston Medical Supply Co EV-to-EBIT Related Terms
Winston Medical Supply Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Winston Medical Supply Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winston Medical Supply Co EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Winston Medical Supply Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Winston Medical Supply Co's EV-to-EBIT falls into.
Winston Medical Supply Co's current Enterprise Value is NT$520.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Winston Medical Supply Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was NT$104.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Winston Medical Supply Co (ROCO:6817) has a EV-to-EBIT of 4.97 as of Sep. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Winston Medical Supply Co and its competitors. This is 51% below median its historical median of 10.17. Over the past decade, Winston Medical Supply Co's EV-to-EBIT has ranged from 3.79 to 49.88. According to the industry distribution chart, Winston Medical Supply Co ranks #75 out of 682 companies in the Drug Manufacturers industry, placing it in the top 11%.
Is Winston Medical Supply Co's EV-to-EBIT too high?
Winston Medical Supply Co's current EV-to-EBIT of 4.97 is 51% below median its 10-year median of 10.17. Over the past 10 years, this metric has ranged from a low of 3.79 to a high of 49.88. The Drug Manufacturers industry median EV-to-EBIT is 16.04. Winston Medical Supply Co's value of 4.97 is 69% below this industry median. Based on the distribution chart, Winston Medical Supply Co ranks #75 out of 682 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Winston Medical Supply Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Winston Medical Supply Co's EV-to-EBIT compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Winston Medical Supply Co ranks #75 out of 682 companies for EV-to-EBIT. This places Winston Medical Supply Co in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 16.04. Winston Medical Supply Co's value of 4.97 is 69% below this benchmark. Historically, Winston Medical Supply Co's own EV-to-EBIT has ranged from 3.79 to 49.88 over the past decade. While the company's 10-year median is 10.17 vs. the industry median of 16.04, Winston Medical Supply Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 16.04, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winston Medical Supply Co's current EV-to-EBIT of 4.97 is 69% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Winston Medical Supply Co and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 16.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winston Medical Supply Co's current EV-to-EBIT is 4.97, which is 51% below median its own 10-year median of 10.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winston Medical Supply Co stock overvalued right now?
Based on GuruFocus' analysis, Winston Medical Supply Co (ROCO:6817) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$87.89, compared to a current price of NT$42.10 — trading 52.1% below its estimated fair value. The current EV-to-EBIT is 4.97, which is 51% below median its 10-year median of 10.17 and 69% below the Drug Manufacturers industry median of 16.04. Winston Medical Supply Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Winston Medical Supply Co (ROCO:6817), the current EV-to-EBIT is 4.97 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winston Medical Supply Co (ROCO:6817) Overvalued in 2026?
Based on GuruFocus' analysis, Winston Medical Supply Co stock appears to be undervalued.
The current stock price of NT$42.10 is trading 52.1% below its estimated GF Value™ of NT$87.89.
GuruFocus considers Winston Medical Supply Co to be Significantly Undervalued.
Key valuation signals for ROCO:6817:
EV-to-EBIT: 4.97 (51% below median its 10-year median of 10.17)
GF Value™: NT$87.89 vs. price of NT$42.10 (52.1% below fair value)
Industry Position: 69% below the Drug Manufacturers median (#75 of 682)
No single metric tells the full story. See the ROCO:6817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winston Medical Supply Co Ltd is a manufacturer of medical products. It produces sterile ophthalmic preparations, hormone preparations and healthy products.
84GF Score
Get the complete analysis for ROCO:6817
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6817 has been successfully added to your 
